The Dow Jones index saw a slight decline on Monday, but U.S.-listed Chinese companies experienced significant gains, fueled by optimism surrounding stimulus efforts and positive PMI data. Prime Medicine, Inc. (PRME) saw a major jump after announcing a collaboration with Bristol Myers Squibb, while other companies like Uxin Limited (UXIN) and UP Fintech Holding Limited (TIGR) also saw substantial growth.